A natural history of familial platelet disorder with myeloid malignancy; HEXIM1 as an essential transcription regulator in erythropoiesis; residual disease predicts relapse in CML patients
This Blood Podcast episode covers a natural history study of familial platelet disorder with myeloid malignancy, the function of HEXIM1 in erythropoiesis, and the use of residual disease to predict relapse in CML patients discontinuing TKI therapy.